nodes	percent_of_prediction	percent_of_DWPC	metapath
Isotretinoin—Blood creatinine increased—Mesalazine—Crohn's disease	0.00212	0.00216	CcSEcCtD
Isotretinoin—Pancreatitis—Azathioprine—Crohn's disease	0.0021	0.00214	CcSEcCtD
Isotretinoin—Memory impairment—Prednisone—Crohn's disease	0.0021	0.00214	CcSEcCtD
Isotretinoin—Dry skin—Mesalazine—Crohn's disease	0.00207	0.00211	CcSEcCtD
Isotretinoin—Abdominal discomfort—Azathioprine—Crohn's disease	0.00206	0.00209	CcSEcCtD
Isotretinoin—Oedema—Mercaptopurine—Crohn's disease	0.00205	0.00208	CcSEcCtD
Isotretinoin—Nasopharyngitis—Mesalazine—Crohn's disease	0.00202	0.00206	CcSEcCtD
Isotretinoin—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.002	0.00204	CcSEcCtD
Isotretinoin—Gastritis—Mesalazine—Crohn's disease	0.002	0.00204	CcSEcCtD
Isotretinoin—Skin disorder—Mercaptopurine—Crohn's disease	0.00199	0.00202	CcSEcCtD
Isotretinoin—Abdominal distension—Mesalazine—Crohn's disease	0.00197	0.002	CcSEcCtD
Isotretinoin—Acne—Prednisone—Crohn's disease	0.00196	0.00199	CcSEcCtD
Isotretinoin—Dysphagia—Mesalazine—Crohn's disease	0.00195	0.00199	CcSEcCtD
Isotretinoin—Asthma—Mesalazine—Crohn's disease	0.00195	0.00199	CcSEcCtD
Isotretinoin—Anorexia—Mercaptopurine—Crohn's disease	0.00195	0.00199	CcSEcCtD
Isotretinoin—Pneumonia—Azathioprine—Crohn's disease	0.00192	0.00196	CcSEcCtD
Isotretinoin—Bronchospasm—Mesalazine—Crohn's disease	0.00192	0.00196	CcSEcCtD
Isotretinoin—Pancreatitis—Mesalazine—Crohn's disease	0.00191	0.00195	CcSEcCtD
Isotretinoin—Infestation NOS—Azathioprine—Crohn's disease	0.00191	0.00195	CcSEcCtD
Isotretinoin—Infestation—Azathioprine—Crohn's disease	0.00191	0.00195	CcSEcCtD
Isotretinoin—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.0019	0.00193	CcSEcCtD
Isotretinoin—Contusion—Prednisone—Crohn's disease	0.00189	0.00192	CcSEcCtD
Isotretinoin—Abdominal discomfort—Mesalazine—Crohn's disease	0.00187	0.00191	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00186	0.0019	CcSEcCtD
Isotretinoin—Dysuria—Mesalazine—Crohn's disease	0.00183	0.00186	CcSEcCtD
Isotretinoin—Neutropenia—Mesalazine—Crohn's disease	0.00183	0.00186	CcSEcCtD
Isotretinoin—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.00181	0.00185	CcSEcCtD
Isotretinoin—RXRG—a6b1 and a6b4 Integrin signaling—MST1—Crohn's disease	0.00181	0.102	CbGpPWpGaD
Isotretinoin—Pollakiuria—Mesalazine—Crohn's disease	0.0018	0.00184	CcSEcCtD
Isotretinoin—Agranulocytosis—Azathioprine—Crohn's disease	0.00178	0.00182	CcSEcCtD
Isotretinoin—Photosensitivity reaction—Mesalazine—Crohn's disease	0.00178	0.00181	CcSEcCtD
Isotretinoin—Decreased appetite—Mercaptopurine—Crohn's disease	0.00178	0.00181	CcSEcCtD
Isotretinoin—Weight increased—Mesalazine—Crohn's disease	0.00178	0.00181	CcSEcCtD
Isotretinoin—Weight decreased—Mesalazine—Crohn's disease	0.00177	0.0018	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00177	0.0018	CcSEcCtD
Isotretinoin—Leukocytosis—Prednisone—Crohn's disease	0.00175	0.00178	CcSEcCtD
Isotretinoin—Pneumonia—Mesalazine—Crohn's disease	0.00175	0.00178	CcSEcCtD
Isotretinoin—Infestation—Mesalazine—Crohn's disease	0.00174	0.00177	CcSEcCtD
Isotretinoin—Infestation NOS—Mesalazine—Crohn's disease	0.00174	0.00177	CcSEcCtD
Isotretinoin—Ulcer—Prednisone—Crohn's disease	0.00174	0.00177	CcSEcCtD
Isotretinoin—Hypercholesterolaemia—Prednisone—Crohn's disease	0.00174	0.00177	CcSEcCtD
Isotretinoin—Depression—Mesalazine—Crohn's disease	0.00174	0.00177	CcSEcCtD
Isotretinoin—Cataract—Prednisone—Crohn's disease	0.00173	0.00176	CcSEcCtD
Isotretinoin—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.00173	0.00176	CcSEcCtD
Isotretinoin—Haemoglobin—Azathioprine—Crohn's disease	0.00172	0.00176	CcSEcCtD
Isotretinoin—Haemorrhage—Azathioprine—Crohn's disease	0.00172	0.00175	CcSEcCtD
Isotretinoin—Renal failure—Mesalazine—Crohn's disease	0.00171	0.00174	CcSEcCtD
Isotretinoin—Neuropathy peripheral—Mesalazine—Crohn's disease	0.00171	0.00174	CcSEcCtD
Isotretinoin—RXRB—a6b1 and a6b4 Integrin signaling—MST1—Crohn's disease	0.0017	0.0956	CbGpPWpGaD
Isotretinoin—Stomatitis—Mesalazine—Crohn's disease	0.0017	0.00173	CcSEcCtD
Isotretinoin—Urinary tract infection—Mesalazine—Crohn's disease	0.00169	0.00172	CcSEcCtD
Isotretinoin—Conjunctivitis—Mesalazine—Crohn's disease	0.00169	0.00172	CcSEcCtD
Isotretinoin—Vasculitis—Prednisone—Crohn's disease	0.00169	0.00172	CcSEcCtD
Isotretinoin—Sweating—Mesalazine—Crohn's disease	0.00167	0.0017	CcSEcCtD
Isotretinoin—Haematuria—Mesalazine—Crohn's disease	0.00166	0.00169	CcSEcCtD
Isotretinoin—Epistaxis—Mesalazine—Crohn's disease	0.00164	0.00167	CcSEcCtD
Isotretinoin—Sinusitis—Mesalazine—Crohn's disease	0.00163	0.00166	CcSEcCtD
Isotretinoin—Agranulocytosis—Mesalazine—Crohn's disease	0.00162	0.00165	CcSEcCtD
Isotretinoin—Erythema multiforme—Azathioprine—Crohn's disease	0.00162	0.00165	CcSEcCtD
Isotretinoin—Body temperature increased—Mercaptopurine—Crohn's disease	0.00162	0.00165	CcSEcCtD
Isotretinoin—Skin exfoliation—Prednisone—Crohn's disease	0.00157	0.0016	CcSEcCtD
Isotretinoin—Haemoglobin—Mesalazine—Crohn's disease	0.00157	0.0016	CcSEcCtD
Isotretinoin—Hepatitis—Mesalazine—Crohn's disease	0.00156	0.00159	CcSEcCtD
Isotretinoin—Haemorrhage—Mesalazine—Crohn's disease	0.00156	0.00159	CcSEcCtD
Isotretinoin—Pharyngitis—Mesalazine—Crohn's disease	0.00155	0.00158	CcSEcCtD
Isotretinoin—Urinary tract disorder—Mesalazine—Crohn's disease	0.00154	0.00157	CcSEcCtD
Isotretinoin—Oedema peripheral—Mesalazine—Crohn's disease	0.00154	0.00157	CcSEcCtD
Isotretinoin—Chills—Azathioprine—Crohn's disease	0.00154	0.00157	CcSEcCtD
Isotretinoin—Arrhythmia—Azathioprine—Crohn's disease	0.00153	0.00156	CcSEcCtD
Isotretinoin—Urethral disorder—Mesalazine—Crohn's disease	0.00153	0.00156	CcSEcCtD
Isotretinoin—Alopecia—Azathioprine—Crohn's disease	0.00152	0.00154	CcSEcCtD
Isotretinoin—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00151	0.00153	CcSEcCtD
Isotretinoin—Oesophagitis—Prednisone—Crohn's disease	0.0015	0.00153	CcSEcCtD
Isotretinoin—Erythema multiforme—Mesalazine—Crohn's disease	0.00148	0.0015	CcSEcCtD
Isotretinoin—Pulmonary oedema—Prednisone—Crohn's disease	0.00147	0.00149	CcSEcCtD
Isotretinoin—Eye disorder—Mesalazine—Crohn's disease	0.00146	0.00149	CcSEcCtD
Isotretinoin—Tinnitus—Mesalazine—Crohn's disease	0.00146	0.00148	CcSEcCtD
Isotretinoin—Sepsis—Prednisone—Crohn's disease	0.00143	0.00146	CcSEcCtD
Isotretinoin—Angiopathy—Mesalazine—Crohn's disease	0.00142	0.00144	CcSEcCtD
Isotretinoin—Euphoric mood—Prednisone—Crohn's disease	0.00141	0.00144	CcSEcCtD
Isotretinoin—Chills—Mesalazine—Crohn's disease	0.0014	0.00143	CcSEcCtD
Isotretinoin—Diarrhoea—Mercaptopurine—Crohn's disease	0.0014	0.00143	CcSEcCtD
Isotretinoin—Ill-defined disorder—Azathioprine—Crohn's disease	0.00139	0.00141	CcSEcCtD
Isotretinoin—Alopecia—Mesalazine—Crohn's disease	0.00138	0.00141	CcSEcCtD
Isotretinoin—Anaemia—Azathioprine—Crohn's disease	0.00138	0.00141	CcSEcCtD
Isotretinoin—Diabetes mellitus—Prednisone—Crohn's disease	0.00137	0.0014	CcSEcCtD
Isotretinoin—Mental disorder—Mesalazine—Crohn's disease	0.00137	0.00139	CcSEcCtD
Isotretinoin—Erythema—Mesalazine—Crohn's disease	0.00136	0.00139	CcSEcCtD
Isotretinoin—Malaise—Azathioprine—Crohn's disease	0.00135	0.00137	CcSEcCtD
Isotretinoin—Flatulence—Mesalazine—Crohn's disease	0.00134	0.00137	CcSEcCtD
Isotretinoin—Tension—Mesalazine—Crohn's disease	0.00134	0.00136	CcSEcCtD
Isotretinoin—Nervousness—Mesalazine—Crohn's disease	0.00132	0.00135	CcSEcCtD
Isotretinoin—Cardiac failure congestive—Prednisone—Crohn's disease	0.00132	0.00134	CcSEcCtD
Isotretinoin—Back pain—Mesalazine—Crohn's disease	0.00132	0.00134	CcSEcCtD
Isotretinoin—Vomiting—Mercaptopurine—Crohn's disease	0.0013	0.00132	CcSEcCtD
Isotretinoin—Rash—Mercaptopurine—Crohn's disease	0.00129	0.00131	CcSEcCtD
Isotretinoin—Dermatitis—Mercaptopurine—Crohn's disease	0.00129	0.00131	CcSEcCtD
Isotretinoin—Vision blurred—Mesalazine—Crohn's disease	0.00128	0.00131	CcSEcCtD
Isotretinoin—Tremor—Mesalazine—Crohn's disease	0.00127	0.0013	CcSEcCtD
Isotretinoin—Arthralgia—Azathioprine—Crohn's disease	0.00127	0.00129	CcSEcCtD
Isotretinoin—Myalgia—Azathioprine—Crohn's disease	0.00127	0.00129	CcSEcCtD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00126	0.00129	CcSEcCtD
Isotretinoin—Ill-defined disorder—Mesalazine—Crohn's disease	0.00126	0.00129	CcSEcCtD
Isotretinoin—Anaemia—Mesalazine—Crohn's disease	0.00126	0.00128	CcSEcCtD
Isotretinoin—Discomfort—Azathioprine—Crohn's disease	0.00126	0.00128	CcSEcCtD
Isotretinoin—Malaise—Mesalazine—Crohn's disease	0.00123	0.00125	CcSEcCtD
Isotretinoin—Cardiac failure—Prednisone—Crohn's disease	0.00122	0.00125	CcSEcCtD
Isotretinoin—Syncope—Mesalazine—Crohn's disease	0.00122	0.00124	CcSEcCtD
Isotretinoin—Lethargy—Prednisone—Crohn's disease	0.00122	0.00124	CcSEcCtD
Isotretinoin—Nausea—Mercaptopurine—Crohn's disease	0.00122	0.00124	CcSEcCtD
Isotretinoin—Infection—Azathioprine—Crohn's disease	0.00121	0.00123	CcSEcCtD
Isotretinoin—Palpitations—Mesalazine—Crohn's disease	0.0012	0.00122	CcSEcCtD
Isotretinoin—Loss of consciousness—Mesalazine—Crohn's disease	0.0012	0.00122	CcSEcCtD
Isotretinoin—Osteoarthritis—Prednisone—Crohn's disease	0.0012	0.00122	CcSEcCtD
Isotretinoin—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	0.0012	0.00122	CcSEcCtD
Isotretinoin—Thrombocytopenia—Azathioprine—Crohn's disease	0.00119	0.00122	CcSEcCtD
Isotretinoin—Cough—Mesalazine—Crohn's disease	0.00119	0.00121	CcSEcCtD
Isotretinoin—Skin disorder—Azathioprine—Crohn's disease	0.00118	0.00121	CcSEcCtD
Isotretinoin—Affect lability—Prednisone—Crohn's disease	0.00118	0.0012	CcSEcCtD
Isotretinoin—Hypertension—Mesalazine—Crohn's disease	0.00117	0.0012	CcSEcCtD
Isotretinoin—Psychotic disorder—Prednisone—Crohn's disease	0.00117	0.00119	CcSEcCtD
Isotretinoin—Myalgia—Mesalazine—Crohn's disease	0.00116	0.00118	CcSEcCtD
Isotretinoin—Arthralgia—Mesalazine—Crohn's disease	0.00116	0.00118	CcSEcCtD
Isotretinoin—Chest pain—Mesalazine—Crohn's disease	0.00116	0.00118	CcSEcCtD
Isotretinoin—Anxiety—Mesalazine—Crohn's disease	0.00115	0.00118	CcSEcCtD
Isotretinoin—Face oedema—Prednisone—Crohn's disease	0.00115	0.00118	CcSEcCtD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00115	0.00117	CcSEcCtD
Isotretinoin—Discomfort—Mesalazine—Crohn's disease	0.00114	0.00117	CcSEcCtD
Isotretinoin—Irritability—Prednisone—Crohn's disease	0.00114	0.00116	CcSEcCtD
Isotretinoin—Hypotension—Azathioprine—Crohn's disease	0.00114	0.00116	CcSEcCtD
Isotretinoin—Cardiac arrest—Prednisone—Crohn's disease	0.00114	0.00116	CcSEcCtD
Isotretinoin—Dry mouth—Mesalazine—Crohn's disease	0.00113	0.00115	CcSEcCtD
Isotretinoin—Mood swings—Prednisone—Crohn's disease	0.00113	0.00115	CcSEcCtD
Isotretinoin—Confusional state—Mesalazine—Crohn's disease	0.00112	0.00114	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00111	0.00113	CcSEcCtD
Isotretinoin—Anaphylactic shock—Mesalazine—Crohn's disease	0.00111	0.00113	CcSEcCtD
Isotretinoin—Oedema—Mesalazine—Crohn's disease	0.00111	0.00113	CcSEcCtD
Isotretinoin—Infection—Mesalazine—Crohn's disease	0.0011	0.00112	CcSEcCtD
Isotretinoin—Dry skin—Prednisone—Crohn's disease	0.0011	0.00112	CcSEcCtD
Isotretinoin—Shock—Mesalazine—Crohn's disease	0.00109	0.00111	CcSEcCtD
Isotretinoin—Nervous system disorder—Mesalazine—Crohn's disease	0.00109	0.00111	CcSEcCtD
Isotretinoin—Thrombocytopenia—Mesalazine—Crohn's disease	0.00109	0.00111	CcSEcCtD
Isotretinoin—Tachycardia—Mesalazine—Crohn's disease	0.00108	0.0011	CcSEcCtD
Isotretinoin—Skin disorder—Mesalazine—Crohn's disease	0.00108	0.0011	CcSEcCtD
Isotretinoin—Hyperhidrosis—Mesalazine—Crohn's disease	0.00107	0.00109	CcSEcCtD
Isotretinoin—Anorexia—Mesalazine—Crohn's disease	0.00106	0.00108	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.00105	0.00107	CcSEcCtD
Isotretinoin—Abdominal distension—Prednisone—Crohn's disease	0.00104	0.00106	CcSEcCtD
Isotretinoin—Hypotension—Mesalazine—Crohn's disease	0.00104	0.00106	CcSEcCtD
Isotretinoin—Pancreatitis—Prednisone—Crohn's disease	0.00101	0.00103	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.00101	0.00103	CcSEcCtD
Isotretinoin—Sweating increased—Prednisone—Crohn's disease	0.00101	0.00102	CcSEcCtD
Isotretinoin—Feeling abnormal—Azathioprine—Crohn's disease	0.001	0.00102	CcSEcCtD
Isotretinoin—Insomnia—Mesalazine—Crohn's disease	0.001	0.00102	CcSEcCtD
Isotretinoin—Paraesthesia—Mesalazine—Crohn's disease	0.000997	0.00102	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000997	0.00102	CcSEcCtD
Isotretinoin—Dyspnoea—Mesalazine—Crohn's disease	0.00099	0.00101	CcSEcCtD
Isotretinoin—Somnolence—Mesalazine—Crohn's disease	0.000987	0.00101	CcSEcCtD
Isotretinoin—Dyspepsia—Mesalazine—Crohn's disease	0.000978	0.000995	CcSEcCtD
Isotretinoin—Neutropenia—Prednisone—Crohn's disease	0.000966	0.000984	CcSEcCtD
Isotretinoin—Decreased appetite—Mesalazine—Crohn's disease	0.000965	0.000983	CcSEcCtD
Isotretinoin—Abdominal pain—Azathioprine—Crohn's disease	0.000964	0.000981	CcSEcCtD
Isotretinoin—Body temperature increased—Azathioprine—Crohn's disease	0.000964	0.000981	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000959	0.000976	CcSEcCtD
Isotretinoin—Fatigue—Mesalazine—Crohn's disease	0.000957	0.000975	CcSEcCtD
Isotretinoin—Pain—Mesalazine—Crohn's disease	0.00095	0.000967	CcSEcCtD
Isotretinoin—Constipation—Mesalazine—Crohn's disease	0.00095	0.000967	CcSEcCtD
Isotretinoin—Weight increased—Prednisone—Crohn's disease	0.00094	0.000957	CcSEcCtD
Isotretinoin—Weight decreased—Prednisone—Crohn's disease	0.000935	0.000952	CcSEcCtD
Isotretinoin—Depression—Prednisone—Crohn's disease	0.000919	0.000935	CcSEcCtD
Isotretinoin—Feeling abnormal—Mesalazine—Crohn's disease	0.000915	0.000932	CcSEcCtD
Isotretinoin—Acute coronary syndrome—Prednisone—Crohn's disease	0.000908	0.000925	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000908	0.000925	CcSEcCtD
Isotretinoin—Myocardial infarction—Prednisone—Crohn's disease	0.000903	0.000919	CcSEcCtD
Isotretinoin—Neuropathy peripheral—Prednisone—Crohn's disease	0.000903	0.000919	CcSEcCtD
Isotretinoin—Hypersensitivity—Azathioprine—Crohn's disease	0.000898	0.000915	CcSEcCtD
Isotretinoin—RXRA—a6b1 and a6b4 Integrin signaling—MST1—Crohn's disease	0.000887	0.0498	CbGpPWpGaD
Isotretinoin—Urticaria—Mesalazine—Crohn's disease	0.000882	0.000898	CcSEcCtD
Isotretinoin—Body temperature increased—Mesalazine—Crohn's disease	0.000878	0.000894	CcSEcCtD
Isotretinoin—Abdominal pain—Mesalazine—Crohn's disease	0.000878	0.000894	CcSEcCtD
Isotretinoin—Diarrhoea—Azathioprine—Crohn's disease	0.000834	0.000849	CcSEcCtD
Isotretinoin—Haemoglobin—Prednisone—Crohn's disease	0.000831	0.000846	CcSEcCtD
Isotretinoin—Haemorrhage—Prednisone—Crohn's disease	0.000827	0.000842	CcSEcCtD
Isotretinoin—Hallucination—Prednisone—Crohn's disease	0.000823	0.000838	CcSEcCtD
Isotretinoin—Hypersensitivity—Mesalazine—Crohn's disease	0.000818	0.000833	CcSEcCtD
Isotretinoin—Dizziness—Azathioprine—Crohn's disease	0.000806	0.000821	CcSEcCtD
Isotretinoin—Asthenia—Mesalazine—Crohn's disease	0.000797	0.000811	CcSEcCtD
Isotretinoin—Pruritus—Mesalazine—Crohn's disease	0.000786	0.0008	CcSEcCtD
Isotretinoin—Vomiting—Azathioprine—Crohn's disease	0.000775	0.000789	CcSEcCtD
Isotretinoin—Eye disorder—Prednisone—Crohn's disease	0.000773	0.000787	CcSEcCtD
Isotretinoin—Rash—Azathioprine—Crohn's disease	0.000769	0.000783	CcSEcCtD
Isotretinoin—Dermatitis—Azathioprine—Crohn's disease	0.000768	0.000782	CcSEcCtD
Isotretinoin—Flushing—Prednisone—Crohn's disease	0.000768	0.000781	CcSEcCtD
Isotretinoin—Headache—Azathioprine—Crohn's disease	0.000764	0.000778	CcSEcCtD
Isotretinoin—Diarrhoea—Mesalazine—Crohn's disease	0.00076	0.000774	CcSEcCtD
Isotretinoin—Angiopathy—Prednisone—Crohn's disease	0.00075	0.000764	CcSEcCtD
Isotretinoin—Arrhythmia—Prednisone—Crohn's disease	0.000739	0.000752	CcSEcCtD
Isotretinoin—Dizziness—Mesalazine—Crohn's disease	0.000734	0.000748	CcSEcCtD
Isotretinoin—Alopecia—Prednisone—Crohn's disease	0.000731	0.000744	CcSEcCtD
Isotretinoin—Mental disorder—Prednisone—Crohn's disease	0.000725	0.000738	CcSEcCtD
Isotretinoin—Nausea—Azathioprine—Crohn's disease	0.000724	0.000737	CcSEcCtD
Isotretinoin—Erythema—Prednisone—Crohn's disease	0.00072	0.000733	CcSEcCtD
Isotretinoin—Malnutrition—Prednisone—Crohn's disease	0.00072	0.000733	CcSEcCtD
Isotretinoin—Vomiting—Mesalazine—Crohn's disease	0.000706	0.000719	CcSEcCtD
Isotretinoin—Rash—Mesalazine—Crohn's disease	0.0007	0.000713	CcSEcCtD
Isotretinoin—Dermatitis—Mesalazine—Crohn's disease	0.0007	0.000712	CcSEcCtD
Isotretinoin—Headache—Mesalazine—Crohn's disease	0.000696	0.000708	CcSEcCtD
Isotretinoin—Vision blurred—Prednisone—Crohn's disease	0.000678	0.000691	CcSEcCtD
Isotretinoin—Ill-defined disorder—Prednisone—Crohn's disease	0.000668	0.00068	CcSEcCtD
Isotretinoin—Anaemia—Prednisone—Crohn's disease	0.000665	0.000677	CcSEcCtD
Isotretinoin—Agitation—Prednisone—Crohn's disease	0.000662	0.000674	CcSEcCtD
Isotretinoin—Nausea—Mesalazine—Crohn's disease	0.00066	0.000672	CcSEcCtD
Isotretinoin—Malaise—Prednisone—Crohn's disease	0.000649	0.000661	CcSEcCtD
Isotretinoin—Syncope—Prednisone—Crohn's disease	0.000646	0.000657	CcSEcCtD
Isotretinoin—Loss of consciousness—Prednisone—Crohn's disease	0.000633	0.000644	CcSEcCtD
Isotretinoin—Convulsion—Prednisone—Crohn's disease	0.000624	0.000635	CcSEcCtD
Isotretinoin—Hypertension—Prednisone—Crohn's disease	0.000622	0.000633	CcSEcCtD
Isotretinoin—Myalgia—Prednisone—Crohn's disease	0.000613	0.000624	CcSEcCtD
Isotretinoin—Arthralgia—Prednisone—Crohn's disease	0.000613	0.000624	CcSEcCtD
Isotretinoin—Anxiety—Prednisone—Crohn's disease	0.000611	0.000622	CcSEcCtD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.000609	0.00062	CcSEcCtD
Isotretinoin—Discomfort—Prednisone—Crohn's disease	0.000606	0.000617	CcSEcCtD
Isotretinoin—Anaphylactic shock—Prednisone—Crohn's disease	0.000588	0.000598	CcSEcCtD
Isotretinoin—Oedema—Prednisone—Crohn's disease	0.000588	0.000598	CcSEcCtD
Isotretinoin—Infection—Prednisone—Crohn's disease	0.000584	0.000594	CcSEcCtD
Isotretinoin—Shock—Prednisone—Crohn's disease	0.000578	0.000589	CcSEcCtD
Isotretinoin—Nervous system disorder—Prednisone—Crohn's disease	0.000576	0.000587	CcSEcCtD
Isotretinoin—Tachycardia—Prednisone—Crohn's disease	0.000573	0.000584	CcSEcCtD
Isotretinoin—Skin disorder—Prednisone—Crohn's disease	0.000571	0.000581	CcSEcCtD
Isotretinoin—Hyperhidrosis—Prednisone—Crohn's disease	0.000568	0.000578	CcSEcCtD
Isotretinoin—Anorexia—Prednisone—Crohn's disease	0.00056	0.00057	CcSEcCtD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	0.000558	0.0314	CbGpPWpGaD
Isotretinoin—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000535	0.000545	CcSEcCtD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	0.000535	0.0301	CbGpPWpGaD
Isotretinoin—Insomnia—Prednisone—Crohn's disease	0.000531	0.000541	CcSEcCtD
Isotretinoin—Paraesthesia—Prednisone—Crohn's disease	0.000528	0.000537	CcSEcCtD
Isotretinoin—Dyspepsia—Prednisone—Crohn's disease	0.000517	0.000527	CcSEcCtD
Isotretinoin—Decreased appetite—Prednisone—Crohn's disease	0.000511	0.00052	CcSEcCtD
Isotretinoin—Fatigue—Prednisone—Crohn's disease	0.000507	0.000516	CcSEcCtD
Isotretinoin—Constipation—Prednisone—Crohn's disease	0.000502	0.000512	CcSEcCtD
Isotretinoin—Feeling abnormal—Prednisone—Crohn's disease	0.000484	0.000493	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Prednisone—Crohn's disease	0.00048	0.000489	CcSEcCtD
Isotretinoin—Urticaria—Prednisone—Crohn's disease	0.000467	0.000475	CcSEcCtD
Isotretinoin—Abdominal pain—Prednisone—Crohn's disease	0.000464	0.000473	CcSEcCtD
Isotretinoin—Body temperature increased—Prednisone—Crohn's disease	0.000464	0.000473	CcSEcCtD
Isotretinoin—Hypersensitivity—Prednisone—Crohn's disease	0.000433	0.000441	CcSEcCtD
Isotretinoin—Asthenia—Prednisone—Crohn's disease	0.000422	0.000429	CcSEcCtD
Isotretinoin—RXRA—Recycling of bile acids and salts—ALB—Crohn's disease	0.000416	0.0234	CbGpPWpGaD
Isotretinoin—Pruritus—Prednisone—Crohn's disease	0.000416	0.000423	CcSEcCtD
Isotretinoin—Diarrhoea—Prednisone—Crohn's disease	0.000402	0.000409	CcSEcCtD
Isotretinoin—Dizziness—Prednisone—Crohn's disease	0.000389	0.000396	CcSEcCtD
Isotretinoin—Vomiting—Prednisone—Crohn's disease	0.000374	0.00038	CcSEcCtD
Isotretinoin—RARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—Crohn's disease	0.000372	0.0209	CbGpPWpGaD
Isotretinoin—Rash—Prednisone—Crohn's disease	0.00037	0.000377	CcSEcCtD
Isotretinoin—Dermatitis—Prednisone—Crohn's disease	0.00037	0.000377	CcSEcCtD
Isotretinoin—Headache—Prednisone—Crohn's disease	0.000368	0.000375	CcSEcCtD
Isotretinoin—Nausea—Prednisone—Crohn's disease	0.000349	0.000355	CcSEcCtD
Isotretinoin—RXRG—RXR and RAR heterodimerization with other nuclear receptor—TNF—Crohn's disease	0.00034	0.0191	CbGpPWpGaD
Isotretinoin—RARB—RXR and RAR heterodimerization with other nuclear receptor—TNF—Crohn's disease	0.000333	0.0187	CbGpPWpGaD
Isotretinoin—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TNF—Crohn's disease	0.00032	0.018	CbGpPWpGaD
Isotretinoin—RARA—RXR and RAR heterodimerization with other nuclear receptor—TNF—Crohn's disease	0.00032	0.018	CbGpPWpGaD
Isotretinoin—RXRA—PPARA activates gene expression—FADS1—Crohn's disease	0.000309	0.0174	CbGpPWpGaD
Isotretinoin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—FADS1—Crohn's disease	0.000302	0.017	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	0.000279	0.0157	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—SOCS1—Crohn's disease	0.000275	0.0154	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—SOCS1—Crohn's disease	0.000258	0.0145	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—SMAD3—Crohn's disease	0.000237	0.0133	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	0.000226	0.0127	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—SMAD3—Crohn's disease	0.000223	0.0125	CbGpPWpGaD
Isotretinoin—RXRA—Bile acid and bile salt metabolism—ALB—Crohn's disease	0.000217	0.0122	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	0.000217	0.0122	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—PTRF—Crohn's disease	0.000211	0.0119	CbGpPWpGaD
Isotretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—FADS1—Crohn's disease	0.000208	0.0117	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—PTRF—Crohn's disease	0.000193	0.0109	CbGpPWpGaD
Isotretinoin—RXRA—Transcription factor regulation in adipogenesis—TNF—Crohn's disease	0.00019	0.0107	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—PTRF—Crohn's disease	0.000189	0.0106	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—PTRF—Crohn's disease	0.000182	0.0102	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—PTRF—Crohn's disease	0.000182	0.0102	CbGpPWpGaD
Isotretinoin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TNF—Crohn's disease	0.000167	0.00936	CbGpPWpGaD
Isotretinoin—RXRA—Transcription factor regulation in adipogenesis—IL6—Crohn's disease	0.000154	0.00863	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—SOCS1—Crohn's disease	0.000135	0.00757	CbGpPWpGaD
Isotretinoin—RARG—Generic Transcription Pathway—UBE2D1—Crohn's disease	0.000132	0.00744	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—ZFP36L1—Crohn's disease	0.000127	0.00711	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000125	0.00704	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—UBE2D1—Crohn's disease	0.000121	0.0068	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—UBE2D1—Crohn's disease	0.000119	0.00667	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—SMAD3—Crohn's disease	0.000116	0.00653	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—ZFP36L1—Crohn's disease	0.000116	0.0065	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—UBE2D1—Crohn's disease	0.000114	0.0064	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—UBE2D1—Crohn's disease	0.000114	0.0064	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—ZFP36L1—Crohn's disease	0.000114	0.00638	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	0.000113	0.00635	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—ZFP36L1—Crohn's disease	0.000109	0.00612	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—ZFP36L1—Crohn's disease	0.000109	0.00612	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—STAT3—Crohn's disease	0.000108	0.00609	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—DNMT3A—Crohn's disease	0.000108	0.00605	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000107	0.00599	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—STAT3—Crohn's disease	0.000102	0.00573	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000101	0.00569	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000101	0.00569	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	0.0001	0.00563	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—DNMT3A—Crohn's disease	9.84e-05	0.00553	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—DNMT3A—Crohn's disease	9.65e-05	0.00542	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	9.6e-05	0.0054	CbGpPWpGaD
Isotretinoin—RARG—Generic Transcription Pathway—SMAD3—Crohn's disease	9.47e-05	0.00532	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—PTRF—Crohn's disease	9.47e-05	0.00532	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—TNF—Crohn's disease	9.38e-05	0.00527	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—DNMT3A—Crohn's disease	9.25e-05	0.0052	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—DNMT3A—Crohn's disease	9.25e-05	0.0052	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—TNF—Crohn's disease	8.82e-05	0.00496	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—SMAD3—Crohn's disease	8.66e-05	0.00487	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—SMAD3—Crohn's disease	8.5e-05	0.00477	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	8.3e-05	0.00466	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—SMAD3—Crohn's disease	8.14e-05	0.00458	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—SMAD3—Crohn's disease	8.14e-05	0.00458	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	7.77e-05	0.00437	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—IL6—Crohn's disease	7.57e-05	0.00425	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—HSPA1B—Crohn's disease	7.27e-05	0.00408	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—GCKR—Crohn's disease	7.14e-05	0.00401	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—IL6—Crohn's disease	7.12e-05	0.004	CbGpPWpGaD
Isotretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—TNF—Crohn's disease	6.99e-05	0.00393	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	6.76e-05	0.0038	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—HSPA1B—Crohn's disease	6.65e-05	0.00374	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—HSPA1B—Crohn's disease	6.52e-05	0.00366	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	6.48e-05	0.00364	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—UBE2D1—Crohn's disease	6.37e-05	0.00358	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	6.31e-05	0.00354	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—HSPA1B—Crohn's disease	6.25e-05	0.00351	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—HSPA1B—Crohn's disease	6.25e-05	0.00351	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—UBE2D1—Crohn's disease	5.93e-05	0.00333	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—UBE2D1—Crohn's disease	5.83e-05	0.00328	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—UBE2D1—Crohn's disease	5.72e-05	0.00321	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—ZFP36L1—Crohn's disease	5.67e-05	0.00319	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PLA2G4F—Crohn's disease	5.58e-05	0.00314	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—UBE2D1—Crohn's disease	5.48e-05	0.00308	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—UBE2D1—Crohn's disease	5.48e-05	0.00308	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—STAT3—Crohn's disease	5.31e-05	0.00298	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	5e-05	0.00281	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—DNMT3A—Crohn's disease	4.82e-05	0.00271	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—MTMR3—Crohn's disease	4.74e-05	0.00267	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—TNF—Crohn's disease	4.6e-05	0.00258	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—SMAD3—Crohn's disease	4.56e-05	0.00256	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—SMAD3—Crohn's disease	4.24e-05	0.00239	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—SMAD3—Crohn's disease	4.17e-05	0.00234	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—SMAD3—Crohn's disease	4.09e-05	0.0023	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—SMAD3—Crohn's disease	4e-05	0.00225	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—SMAD3—Crohn's disease	3.92e-05	0.0022	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—SMAD3—Crohn's disease	3.92e-05	0.0022	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—IL6—Crohn's disease	3.71e-05	0.00208	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—FADS1—Crohn's disease	3.7e-05	0.00208	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GPX4—Crohn's disease	3.46e-05	0.00194	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	3.38e-05	0.0019	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GCKR—Crohn's disease	3.34e-05	0.00188	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—HSPA1B—Crohn's disease	3.26e-05	0.00183	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—UBE2D1—Crohn's disease	2.86e-05	0.00161	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—TYK2—Crohn's disease	2.61e-05	0.00146	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—JAK2—Crohn's disease	2.49e-05	0.0014	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.39e-05	0.00134	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—ALB—Crohn's disease	2.27e-05	0.00128	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.09e-05	0.00117	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—SMAD3—Crohn's disease	2.04e-05	0.00115	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—STAT3—Crohn's disease	1.83e-05	0.00103	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—TNF—Crohn's disease	1.58e-05	0.000888	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—IL6—Crohn's disease	1.27e-05	0.000716	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ALB—Crohn's disease	1.06e-05	0.000598	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PTGS2—Crohn's disease	9.31e-06	0.000523	CbGpPWpGaD
